TriMas (NASDAQ:TRS) Sets New 52-Week Low - Time to Sell?

TriMas Co. (NASDAQ:TRS - Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $22.24 and last traded at $22.30, with a volume of 5301 shares traded. The stock had previously closed at $22.74.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on TRS shares. BWS Financial restated a "buy" rating and set a $40.00 target price on shares of TriMas in a research report on Tuesday, November 5th. StockNews.com raised TriMas from a "sell" rating to a "hold" rating in a research note on Wednesday, November 13th.

TriMas Trading Up 1.7 %

The company has a market capitalization of $938.02 million, a PE ratio of 36.13 and a beta of 0.67. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The business has a fifty day moving average price of $25.78 and a 200 day moving average price of $25.57.

TriMas (NASDAQ:TRS - Get Free Report) last posted its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business had revenue of $229.36 million for the quarter, compared to analyst estimates of $239.33 million. During the same quarter in the previous year, the firm posted $0.57 EPS. The business's revenue was down 2.5% compared to the same quarter last year. Analysts expect that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th were issued a $0.04 dividend. The ex-dividend date of this dividend was Tuesday, November 5th. This represents a $0.16 dividend on an annualized basis and a yield of 0.69%. TriMas's dividend payout ratio is currently 25.00%.

Hedge Funds Weigh In On TriMas

Institutional investors have recently made changes to their positions in the business. Impax Asset Management Group plc lifted its stake in TriMas by 216.4% during the third quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company's stock worth $10,467,000 after purchasing an additional 280,431 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of TriMas by 10.7% in the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company's stock valued at $66,872,000 after buying an additional 252,537 shares during the period. Invenomic Capital Management LP bought a new stake in shares of TriMas during the 3rd quarter valued at about $3,655,000. Western Standard LLC raised its stake in TriMas by 86.6% during the third quarter. Western Standard LLC now owns 169,069 shares of the industrial products company's stock worth $4,316,000 after acquiring an additional 78,450 shares during the period. Finally, Atom Investors LP lifted its holdings in TriMas by 62.0% in the third quarter. Atom Investors LP now owns 179,328 shares of the industrial products company's stock worth $4,578,000 after acquiring an additional 68,608 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.